chipcytometry in a clinical setting

14
ChipCytometry Welcome!

Upload: jan-detmers

Post on 20-Feb-2017

273 views

Category:

Technology


1 download

TRANSCRIPT

Page 1: Chipcytometry in a clinical setting

ChipCytometry

Welcome!

Page 2: Chipcytometry in a clinical setting

Agenda

2

• 10:30 Arrival at Peter Medawar Building for Pathogen Research • 10:45 Chris Willberg: Welcome reception, introduction • 11:15 Christian Hennig: Introduction to Chipcytometry, Deep

Phenotyping and Tissue Cytometry • 11:45 Matthew Bilton: Analysis of MAIT cell populations within

mediastinal lymph nodes. • 12:15 Jan Detmers: Chipcytometry in a clinical setting • 12:30 Lunch • 13:15 visiting the lab • 14:00 Christian Hennig: Chipcytometry case studies, Q&A • 15:30 End of meeting

Page 3: Chipcytometry in a clinical setting

About

3

Zellkraftwerk GmbH

• Hannover, Germany

• 2 Divisions: Instrument Manufacturer – CRO

• CRO: Currently 4 phase I; 2 phase II trials

VA Partner

Page 4: Chipcytometry in a clinical setting

Central Lab Services

4

Fully automated analyzer

24/7 operation

4,000 data points/week

“Spirit of GLP”

Page 5: Chipcytometry in a clinical setting

Global Footprint

5

Sponsor

Central Lab BioBank ZellSafe™Box World Courier

Page 6: Chipcytometry in a clinical setting

Case Study (opticus neuritis)

6

Clinical Neuroimmunology

Page 7: Chipcytometry in a clinical setting

Clinical Neuroimmunology

7

- Disease: Multiple Scler.

- Study: Clinical

- Samples: 650

1. Round 2. Round

Outcome: - Stratification markers - Trial is ongoing

By courtesy of

Page 8: Chipcytometry in a clinical setting

Work Flow

8

2. Load - Load sample, wait 5‘ - Fix (4% PFA), wait 15‘ - rinse, seal chip

1. Prep - 1 ml blood - CPT, Ficoll or RBC lysis - total time: 40’

3. Store - store on-site - temperature 4°C - up to several months

4. Ship GDP Logistics (Good Distribution Practice)

5. Bioanalysis “Spirit of GLP” clinical trial

support (SOP, QA)

6. Re-interrogate Test additional markers over >24 months

Page 9: Chipcytometry in a clinical setting

Cell-based Biomarker Development

9

1: Study Preparation Phase

• SOP / Training Videos / Site Qualification

• On-site Training

2: Sample Collection Phase

• Custom kits with all consumables required

• Monthly / bi-monthly / quarterly sample pick-up according GDP

• Incoming sample QC and bio-banking analogous to GLP

3: Bioanalysis

• Assay / Method Development

• Method Validation analogous to GLP

• Sample analysis including ISR

• Option for sample re-interrogation for 24 months

4: Patient Stratification and Computational Biology

Page 10: Chipcytometry in a clinical setting

Preparing Clinical Trials

Candidate Sites 1, 2, 3, 4,..

2. Site Qualification Kit

1. SOP, Training Video

10

Page 11: Chipcytometry in a clinical setting

Collaborative Cytometry

Core Facility „Democratization“ Collaborate („go to an expert“) („have your own“) (“work with many”)

IT

FACS

11

Page 12: Chipcytometry in a clinical setting

Biomarker Development

12

Clinical Research Center Hannover

Method Development • Preanalytics • Assay Development • Data Processing • Data Management

Pilot Preparation

Planning • Study plan / IPC • IRB • Clinical Database • Site Audit

Clinical trial

Execution • Study Coordinator • Data Collection • Sample Analysis • Sample Logistics • Biobanking

Page 13: Chipcytometry in a clinical setting

Typical Milestone-based Project

13

Study Validation In-Study

Bioanalysis Work

Plan Panel Set-up

+ Controls

Samples Ideas

Page 14: Chipcytometry in a clinical setting

Thank you for your attention!

14

Selected Primary Publications

• Happle, Science Translational, 2014

• Dijkstra, Nature Medicine 2012

• Hennig, Br. J. Hematology 2010

• Woelbeling, Immunobiology 2011

• Polte, JACI 2008

System Validation according to:

• O'Hara, JIM 2011

• Green, JIM 2011

• Cunliffe, Pharm. Res. 2009

• Lee, Pharm. Res. 2006

• Bioanalytical Method Validation, FDA, 2013

“Precision Immunology” References

A B C Control Diseased Groups Group

Focus on: Translational Immunology Mode of Action(MoA) Patient Stratification Clinical Trial Support